catechin has been researched along with Carcinoma, Endometrioid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Araya-Farias, M; Bachvarov, D; Bairati, I; Bazinet, L; Doyen, A; Duchesne, T; Grégoire, J; Labbé, DP; Plante, M; Renaud, MC; Têtu, B; Trudel, D | 1 |
1 trial(s) available for catechin and Carcinoma, Endometrioid
Article | Year |
---|---|
A two-stage, single-arm, phase II study of EGCG-enriched green tea drink as a maintenance therapy in women with advanced stage ovarian cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Endometrioid; Catechin; Combined Modality Therapy; Cystadenocarcinoma, Serous; Disease-Free Survival; Female; Humans; Maintenance Chemotherapy; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Ovarian Neoplasms; Taxoids; Tea | 2013 |